ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 392 % +3%
Quick Ratio 14.18 %
Debt-to-equity -174 % -6.7%
Return On Equity 64.21 % -25.8%
Return On Assets -86.73 % +36.8%
Operating Margin -316 % +93.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 984,965,179 shares +41.3%
Common Stock, Shares, Outstanding 984,965,179 shares +41.3%
Entity Public Float 980,300,000 USD +2.1%
Common Stock, Value, Issued 98,000 USD +40%
Weighted Average Number of Shares Outstanding, Basic 946,601,000 shares +36%
Weighted Average Number of Shares Outstanding, Diluted 946,601,000 shares +35.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 82,555,000 USD +10.3%
Revenue from Contract with Customer, Excluding Assessed Tax 82,555,000 USD +4.3%
Research and Development Expense 190,144,000 USD -18.2%
Costs and Expenses 87,691,000 USD +1.5%
Operating Income (Loss) -260,744,000 USD +27.6%
Nonoperating Income (Expense) -87,949,000 USD +61.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -348,693,000 USD +40.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -348,616,000 USD +40.7%
Earnings Per Share, Basic 0 USD/shares +56.2%
Earnings Per Share, Diluted 0 USD/shares +56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 60,241,000 USD -46.2%
Marketable Securities, Current 197,572,000 USD +9.7%
Accounts Receivable, after Allowance for Credit Loss, Current 32,016,000 USD +6.7%
Inventory, Net 6,703,000 USD +2.4%
Other Assets, Current 2,513,000 USD +83.8%
Assets, Current 329,497,000 USD +1%
Property, Plant and Equipment, Net 129,597,000 USD -7%
Operating Lease, Right-of-Use Asset 33,195,000 USD -5%
Intangible Assets, Net (Excluding Goodwill) 16,058,000 USD -15.4%
Goodwill 910,000 USD 0%
Other Assets, Noncurrent 4,827,000 USD +67.6%
Assets 518,987,000 USD +42.4%
Accounts Payable, Current 33,573,000 USD +2.4%
Accrued Liabilities, Current 43,602,000 USD +0.01%
Liabilities, Current 57,134,000 USD -6.3%
Operating Lease, Liability, Noncurrent 34,130,000 USD -7.2%
Other Liabilities, Noncurrent 702,000 USD -0.43%
Liabilities 1,042,397,000 USD -6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4,997,000 USD +47.5%
Retained Earnings (Accumulated Deficit) -3,664,702,000 USD -10.5%
Stockholders' Equity Attributable to Parent -524,319,000 USD +29.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -523,410,000 USD +29.7%
Liabilities and Equity 518,987,000 USD +42.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -85,905,000 USD +19.7%
Net Cash Provided by (Used in) Financing Activities -982,000 USD -1.1%
Net Cash Provided by (Used in) Investing Activities 4,129,000 USD
Common Stock, Shares Authorized 1,350,000,000 shares 0%
Common Stock, Shares, Issued 984,965,179 shares +41.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -82,768,000 USD +37.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15,593,000 USD -34.8%
Deferred Tax Assets, Valuation Allowance 777,085,000 USD +19.8%
Deferred Tax Assets, Gross 795,409,000 USD +16.5%
Operating Lease, Liability 41,446,000 USD -5.4%
Depreciation 13,800,000 USD -12.7%
Payments to Acquire Property, Plant, and Equipment 1,121,000 USD -11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -343,722,000 USD +41.6%
Lessee, Operating Lease, Liability, to be Paid 53,163,000 USD -9.2%
Property, Plant and Equipment, Gross 238,848,000 USD +1.5%
Operating Lease, Liability, Current 7,316,000 USD +4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10,224,000 USD +5.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 10,899,000 USD -6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11,717,000 USD -18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10,527,000 USD +17.2%
Deferred Tax Assets, Operating Loss Carryforwards 475,130,000 USD +12.9%
Preferred Stock, Shares Authorized 20,000,000 shares
Unrecognized Tax Benefits 34,543,000 USD -2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9,915,000 USD +7.2%
Operating Lease, Payments 2,925,000 USD +22.7%
Amortization of Intangible Assets 2,000,000 USD 0%
Depreciation, Depletion and Amortization 3,829,000 USD -15.9%
Share-based Payment Arrangement, Expense 37,101,000 USD -2.8%
Interest Expense 72,146,000 USD -40.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares